98 related articles for article (PubMed ID: 17669011)
1. Vaccination against periodontitis: the saga continues.
Sharma DC; Prasad SB; Karthikeyan BV
Expert Rev Vaccines; 2007 Aug; 6(4):579-90. PubMed ID: 17669011
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss.
Wilensky A; Potempa J; Houri-Haddad Y; Shapira L
J Periodontal Res; 2017 Apr; 52(2):285-291. PubMed ID: 27282938
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.
Puth S; Hong SH; Park MJ; Lee HH; Lee YS; Jeong K; Kang IC; Koh JT; Moon B; Park SC; Rhee JH; Lee SE
Hum Vaccin Immunother; 2017 Dec; 13(12):2794-2803. PubMed ID: 28604268
[TBL] [Abstract][Full Text] [Related]
4. Immune responses and vaccination against periodontal infections.
Persson GR
J Clin Periodontol; 2005; 32 Suppl 6():39-53. PubMed ID: 16128828
[TBL] [Abstract][Full Text] [Related]
5. Production of protective antibodies against Porphyromonas gingivalis strains by immunization with recombinant gingipain domains.
Yasaki-Inagaki Y; Inagaki S; Yamada S; Okuda K; Ishihara K
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):287-95. PubMed ID: 16831217
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease.
Kinane DF; Mooney J; Ebersole JL
Periodontol 2000; 1999 Jun; 20():289-340. PubMed ID: 10522229
[No Abstract] [Full Text] [Related]
7. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis.
Zhang P; Yang QB; Balkovetz DF; Lewis JP; Clements JD; Michalek SM; Katz J
Vaccine; 2005 Sep; 23(39):4734-44. PubMed ID: 15955601
[TBL] [Abstract][Full Text] [Related]
8. Vaccination and periodontitis: myth or reality.
Page RC
J Int Acad Periodontol; 2000 Apr; 2(2):31-43. PubMed ID: 12666959
[TBL] [Abstract][Full Text] [Related]
9. Passive immunization against dental caries and periodontal disease: development of recombinant and human monoclonal antibodies.
Abiko Y
Crit Rev Oral Biol Med; 2000; 11(2):140-58. PubMed ID: 12002812
[TBL] [Abstract][Full Text] [Related]
10. The protective nature of host responses in periodontal diseases.
Ebersole JL; Taubman MA
Periodontol 2000; 1994 Jun; 5():112-41. PubMed ID: 9673165
[No Abstract] [Full Text] [Related]
11. Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis.
Booth V; Ashley FP; Lehner T
Infect Immun; 1996 Feb; 64(2):422-7. PubMed ID: 8550186
[TBL] [Abstract][Full Text] [Related]
12. Biological plaque control: novel therapeutic approach to periodontal disease.
Sugano N
J Oral Sci; 2012 Mar; 54(1):1-5. PubMed ID: 22466880
[TBL] [Abstract][Full Text] [Related]
13. Immunization of Macaca fascicularis against experimental periodontitis using a vaccine containing cysteine proteases purified from Porphyromonas gingivalis.
Page RC; Lantz MS; Darveau R; Jeffcoat M; Mancl L; Houston L; Braham P; Persson GR
Oral Microbiol Immunol; 2007 Jun; 22(3):162-8. PubMed ID: 17488441
[TBL] [Abstract][Full Text] [Related]
14. Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis.
Moritz AJ; Cappelli D; Lantz MS; Holt SC; Ebersole JL
J Periodontol; 1998 Jun; 69(6):686-97. PubMed ID: 9660338
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of an HA2 domain-based periodontitis vaccine.
DeCarlo AA; Huang Y; Collyer CA; Langley DB; Katz J
Infect Immun; 2003 Jan; 71(1):562-6. PubMed ID: 12496212
[TBL] [Abstract][Full Text] [Related]
16. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen.
Bostanci N; Belibasakis GN
FEMS Microbiol Lett; 2012 Aug; 333(1):1-9. PubMed ID: 22530835
[TBL] [Abstract][Full Text] [Related]
17. Assessment of outer membrane vesicles of periodontopathic bacterium Porphyromonas gingivalis as possible mucosal immunogen.
Nakao R; Hasegawa H; Dongying B; Ohnishi M; Senpuku H
Vaccine; 2016 Aug; 34(38):4626-4634. PubMed ID: 27461458
[TBL] [Abstract][Full Text] [Related]
18. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates.
Persson GR; Engel D; Whitney C; Darveau R; Weinberg A; Brunsvold M; Page RC
Infect Immun; 1994 Mar; 62(3):1026-31. PubMed ID: 8112836
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with recombinant adhesins from the RgpA-Kgp proteinase-adhesin complex protects against Porphyromonas gingivalis infection.
Frazer LT; O'Brien-Simpson NM; Slakeski N; Walsh KA; Veith PD; Chen CG; Barr IG; Reynolds EC
Vaccine; 2006 Oct; 24(42-43):6542-54. PubMed ID: 16839648
[TBL] [Abstract][Full Text] [Related]
20. Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis.
Ishikawa I; Nakashima K; Koseki T; Nagasawa T; Watanabe H; Arakawa S; Nitta H; Nishihara T
Periodontol 2000; 1997 Jun; 14():79-111. PubMed ID: 9567967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
